377 related articles for article (PubMed ID: 34788243)
21. Optic nerve appearance as a predictor of visual outcome in patients with idiopathic intracranial hypertension.
Micieli JA; Bruce BB; Vasseneix C; Blanch RJ; Berezovsky DE; Peragallo JH; Newman NJ; Biousse V
Br J Ophthalmol; 2019 Oct; 103(10):1429-1435. PubMed ID: 30530819
[TBL] [Abstract][Full Text] [Related]
22. Contrast-Enhanced 3D-FLAIR Imaging of the Optic Nerve and Optic Nerve Head: Novel Neuroimaging Findings of Idiopathic Intracranial Hypertension.
Golden E; Krivochenitser R; Mathews N; Longhurst C; Chen Y; Yu JJ; Kennedy TA
AJNR Am J Neuroradiol; 2019 Feb; 40(2):334-339. PubMed ID: 30679213
[TBL] [Abstract][Full Text] [Related]
23. Association between visual parameters and neuroimaging features of idiopathic intracranial hypertension.
Padhye LV; Van Stavern GP; Sharma A; Viets R; Huecker JB; Gordon MO
J Neurol Sci; 2013 Sep; 332(1-2):80-5. PubMed ID: 23850064
[TBL] [Abstract][Full Text] [Related]
24. Neurophysiological visual assessment in patients with idiopathic intracranial hypertension: visual evoked potential and multifocal field electroretinography.
Elgaly MA; Hosny H; El Habashy HR; Hussein M; Magdy R; Elanwar R
BMC Neurol; 2023 May; 23(1):188. PubMed ID: 37165341
[TBL] [Abstract][Full Text] [Related]
25. Presumptive Idiopathic Intracranial Hypertension Based on Neuroimaging Findings: A Referral Pattern Study.
Aung AB; Chen BS; Wicks J; Bruce BB; Meyer BI; Dattilo M; Kedar S; Saindane A; Newman NJ; Biousse V
J Neuroophthalmol; 2023 Mar; 43(1):55-62. PubMed ID: 36166790
[TBL] [Abstract][Full Text] [Related]
26. Retinal Manifestations of Idiopathic Intracranial Hypertension.
Nichani P; Micieli JA
Ophthalmol Retina; 2021 May; 5(5):429-437. PubMed ID: 32860958
[TBL] [Abstract][Full Text] [Related]
27. Evaluating the optic nerve stiffness and optic nerve sheath diameter in idiopathic intracranial hypertension patients after the resolution of papilledema.
Kaya FS; Bayram E; İnci E
Neurol Sci; 2021 Dec; 42(12):5165-5170. PubMed ID: 33788047
[TBL] [Abstract][Full Text] [Related]
28. Utility of Intracranial Pressure Monitoring for Diagnosis of Idiopathic Intracranial Hypertension in the Absence of Papilledema.
Bridges KJ; Raslan AM
World Neurosurg; 2018 Mar; 111():e221-e227. PubMed ID: 29258930
[TBL] [Abstract][Full Text] [Related]
29. Idiopathic intracranial hypertension in atypical demographics.
Donaldson L; Jhaveri A; Micieli J; Margolin E
J Neurol Sci; 2022 Jun; 437():120271. PubMed ID: 35525063
[TBL] [Abstract][Full Text] [Related]
30. Increased intracranial pressure in spontaneous CSF leak patients is not associated with papilledema.
Aaron G; Doyle J; Vaphiades MS; Riley KO; Woodworth BA
Otolaryngol Head Neck Surg; 2014 Dec; 151(6):1061-6. PubMed ID: 25248848
[TBL] [Abstract][Full Text] [Related]
31. The impact of eating disorders on idiopathic intracranial hypertension.
Wallentin T; Linnet J; Lichtenstein MB; Hansen NS; Korsbæk JJ; Høgedal L; Hagen SM; Molander LD; Jensen RH; Beier D
Cephalalgia; 2024 Mar; 44(3):3331024241237237. PubMed ID: 38459955
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of optic nerve sheath on MRI in idiopathic intracranial hypertension(IIH).
Ma Z; Jiang H; Wang J
Clin Neurol Neurosurg; 2023 Aug; 231():107778. PubMed ID: 37348315
[TBL] [Abstract][Full Text] [Related]
33. Venous Sinus Stenting in Idiopathic Intracranial Hypertension: Results of a Prospective Trial.
Dinkin MJ; Patsalides A
J Neuroophthalmol; 2017 Jun; 37(2):113-121. PubMed ID: 27556959
[TBL] [Abstract][Full Text] [Related]
34. Sonographic assessment of the optic nerve and the central retinal artery in idiopathic intracranial hypertension.
Jeub M; Schlapakow E; Ratz M; Kindler C; Schievelkamp AH; Wabbels B; Kornblum C
J Clin Neurosci; 2020 Feb; 72():292-297. PubMed ID: 31540860
[TBL] [Abstract][Full Text] [Related]
35. Optic disc haemorrhages at baseline as a risk factor for poor outcome in the Idiopathic Intracranial Hypertension Treatment Trial.
Wall M; Thurtell MJ;
Br J Ophthalmol; 2017 Sep; 101(9):1256-1260. PubMed ID: 28130349
[TBL] [Abstract][Full Text] [Related]
36. Asymmetric papilledema in idiopathic intracranial hypertension.
Bidot S; Bruce BB; Saindane AM; Newman NJ; Biousse V
J Neuroophthalmol; 2015 Mar; 35(1):31-6. PubMed ID: 25494197
[TBL] [Abstract][Full Text] [Related]
37. Impact of Pregnancy on Papilledema and Vision Loss in Idiopathic Intracranial Hypertension Patients: A Chart Review and Case Series of 13 Patients.
Lambert-Cheatham NA; Nagia L; Pasmanter NR; Pellizzari R; Lee B; Miller NJ; Kaufman DI
J Neuroophthalmol; 2024 Jun; 44(2):206-211. PubMed ID: 37540562
[TBL] [Abstract][Full Text] [Related]
38. Visual outcomes following optic nerve sheath fenestration via the medial transconjunctival approach.
Vaidya NS; Mahmoud AM; Buzzacco D; Katz SE
Orbit; 2016 Oct; 35(5):271-7. PubMed ID: 27541942
[TBL] [Abstract][Full Text] [Related]
39. Optic nerve sheath decompression saves sight in severe papilloedema: results from 81 eyes in 56 patients with pseudotumor cerebri.
Söylev Bajin M; Durmaz Engin C; Yaman A; Ayhan Z; Gökçay F; Çelebisoy N; Men S; Akdal G; Halmágyi GM
Acta Ophthalmol; 2021 Nov; 99(7):e991-e998. PubMed ID: 33377617
[TBL] [Abstract][Full Text] [Related]
40. Low cerebrospinal fluid protein in prepubertal children with idiopathic intracranial hypertension.
Margeta MA; Buckley EG; El-Dairi MA
J AAPOS; 2015 Apr; 19(2):135-9. PubMed ID: 25828820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
